Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy

Guido Rodriguez, Paolo Vitali, Caterina De Leo, Fabrizio De Carli, Nicola Girtler, Flavio Nobili

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Twenty patients affected with probable mild-to-moderate Alzheimer's disease (AD; NINCDS-ADRDA criteria; 14 women and 6 men, mean age 75.2 ± 7.1 years) who regularly received an oral acetylcholinesterase inhibitor (AChEI; donepezil 5 mg/day; Dz group) were compared with a control group of 11 AD patients (6 women and 5 men, mean age 73.5 ± 6.0 years) diagnosed and followed up in the pre-AChEIs era (C group). At basal evaluation (t0), the 2 groups were comparable for age, education, and severity of disease (Global Deterioration Scale). All patients underwent quantitative EEG (qEEG, average reference, 10-20 International System), and were reexamined about 1 year later (t1; i.e., after 12.3 ± 3.6 months the Dz group, and after 13.7 ± 3.9 months the C group). Log-transformed values of two qEEG bands, i.e. 2-6 and 6.5-12 Hz, were averaged between adjacent channels (frontal F3 and F7, F4 and F8; parietotemporal P3 and T7, P4 and T8) to obtain a qEEG ratio (6.5-12/2-6 Hz.) from one frontal and one temporoparietal region in each hemisphere. Neuropsychological impairment was summarized by the Mini-Mental Status Examination (MMSE). At t0, both the MMSE score and the qEEG ratio values were somewhat higher in the C than in the Dz group, although nonsignificantly. Between t0 and t1, the MMSE score decreased significantly (p <0.01) more in the C group (-4.36 ± 2.25) than in the Dz group (-1.45 ± 2.16), as did the qEEG ratio in the right frontal region (p <0.01), whereas in the left frontal region the significance level was not reached (p =0.02). Between t0 and t1, the qEEG ratio difference in both frontal regions and in the right temporoparietal region significantly correlated with the MMSE difference (p <0.01), but neither with time between examinations nor with the difference on the Visual Search Test score. Long-term treatment with Dz led to a lesser deterioration of qEEG, paralleling a milder neuropsychological decline. The effect was significant in frontal regions, possibly because they are relatively spared during the mild-to-moderate phases of the disease.

Original languageEnglish
Pages (from-to)49-56
Number of pages8
JournalNeuropsychobiology
Volume46
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Electroencephalography
Cholinesterase Inhibitors
Alzheimer Disease
Therapeutics
Education
Control Groups
donepezil
cloricromen

Keywords

  • Alzheimer's disease
  • Donepezil
  • Mini-Mental Status Examination
  • Quantitative EEG

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)
  • Psychology(all)

Cite this

Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy. / Rodriguez, Guido; Vitali, Paolo; De Leo, Caterina; De Carli, Fabrizio; Girtler, Nicola; Nobili, Flavio.

In: Neuropsychobiology, Vol. 46, No. 1, 2002, p. 49-56.

Research output: Contribution to journalArticle

Rodriguez, G, Vitali, P, De Leo, C, De Carli, F, Girtler, N & Nobili, F 2002, 'Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy', Neuropsychobiology, vol. 46, no. 1, pp. 49-56. https://doi.org/10.1159/000063576
Rodriguez, Guido ; Vitali, Paolo ; De Leo, Caterina ; De Carli, Fabrizio ; Girtler, Nicola ; Nobili, Flavio. / Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy. In: Neuropsychobiology. 2002 ; Vol. 46, No. 1. pp. 49-56.
@article{fb8b399fcb4547bdb5d0494a5b14ad84,
title = "Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy",
abstract = "Twenty patients affected with probable mild-to-moderate Alzheimer's disease (AD; NINCDS-ADRDA criteria; 14 women and 6 men, mean age 75.2 ± 7.1 years) who regularly received an oral acetylcholinesterase inhibitor (AChEI; donepezil 5 mg/day; Dz group) were compared with a control group of 11 AD patients (6 women and 5 men, mean age 73.5 ± 6.0 years) diagnosed and followed up in the pre-AChEIs era (C group). At basal evaluation (t0), the 2 groups were comparable for age, education, and severity of disease (Global Deterioration Scale). All patients underwent quantitative EEG (qEEG, average reference, 10-20 International System), and were reexamined about 1 year later (t1; i.e., after 12.3 ± 3.6 months the Dz group, and after 13.7 ± 3.9 months the C group). Log-transformed values of two qEEG bands, i.e. 2-6 and 6.5-12 Hz, were averaged between adjacent channels (frontal F3 and F7, F4 and F8; parietotemporal P3 and T7, P4 and T8) to obtain a qEEG ratio (6.5-12/2-6 Hz.) from one frontal and one temporoparietal region in each hemisphere. Neuropsychological impairment was summarized by the Mini-Mental Status Examination (MMSE). At t0, both the MMSE score and the qEEG ratio values were somewhat higher in the C than in the Dz group, although nonsignificantly. Between t0 and t1, the MMSE score decreased significantly (p <0.01) more in the C group (-4.36 ± 2.25) than in the Dz group (-1.45 ± 2.16), as did the qEEG ratio in the right frontal region (p <0.01), whereas in the left frontal region the significance level was not reached (p =0.02). Between t0 and t1, the qEEG ratio difference in both frontal regions and in the right temporoparietal region significantly correlated with the MMSE difference (p <0.01), but neither with time between examinations nor with the difference on the Visual Search Test score. Long-term treatment with Dz led to a lesser deterioration of qEEG, paralleling a milder neuropsychological decline. The effect was significant in frontal regions, possibly because they are relatively spared during the mild-to-moderate phases of the disease.",
keywords = "Alzheimer's disease, Donepezil, Mini-Mental Status Examination, Quantitative EEG",
author = "Guido Rodriguez and Paolo Vitali and {De Leo}, Caterina and {De Carli}, Fabrizio and Nicola Girtler and Flavio Nobili",
year = "2002",
doi = "10.1159/000063576",
language = "English",
volume = "46",
pages = "49--56",
journal = "Neuropsychobiology",
issn = "0302-282X",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy

AU - Rodriguez, Guido

AU - Vitali, Paolo

AU - De Leo, Caterina

AU - De Carli, Fabrizio

AU - Girtler, Nicola

AU - Nobili, Flavio

PY - 2002

Y1 - 2002

N2 - Twenty patients affected with probable mild-to-moderate Alzheimer's disease (AD; NINCDS-ADRDA criteria; 14 women and 6 men, mean age 75.2 ± 7.1 years) who regularly received an oral acetylcholinesterase inhibitor (AChEI; donepezil 5 mg/day; Dz group) were compared with a control group of 11 AD patients (6 women and 5 men, mean age 73.5 ± 6.0 years) diagnosed and followed up in the pre-AChEIs era (C group). At basal evaluation (t0), the 2 groups were comparable for age, education, and severity of disease (Global Deterioration Scale). All patients underwent quantitative EEG (qEEG, average reference, 10-20 International System), and were reexamined about 1 year later (t1; i.e., after 12.3 ± 3.6 months the Dz group, and after 13.7 ± 3.9 months the C group). Log-transformed values of two qEEG bands, i.e. 2-6 and 6.5-12 Hz, were averaged between adjacent channels (frontal F3 and F7, F4 and F8; parietotemporal P3 and T7, P4 and T8) to obtain a qEEG ratio (6.5-12/2-6 Hz.) from one frontal and one temporoparietal region in each hemisphere. Neuropsychological impairment was summarized by the Mini-Mental Status Examination (MMSE). At t0, both the MMSE score and the qEEG ratio values were somewhat higher in the C than in the Dz group, although nonsignificantly. Between t0 and t1, the MMSE score decreased significantly (p <0.01) more in the C group (-4.36 ± 2.25) than in the Dz group (-1.45 ± 2.16), as did the qEEG ratio in the right frontal region (p <0.01), whereas in the left frontal region the significance level was not reached (p =0.02). Between t0 and t1, the qEEG ratio difference in both frontal regions and in the right temporoparietal region significantly correlated with the MMSE difference (p <0.01), but neither with time between examinations nor with the difference on the Visual Search Test score. Long-term treatment with Dz led to a lesser deterioration of qEEG, paralleling a milder neuropsychological decline. The effect was significant in frontal regions, possibly because they are relatively spared during the mild-to-moderate phases of the disease.

AB - Twenty patients affected with probable mild-to-moderate Alzheimer's disease (AD; NINCDS-ADRDA criteria; 14 women and 6 men, mean age 75.2 ± 7.1 years) who regularly received an oral acetylcholinesterase inhibitor (AChEI; donepezil 5 mg/day; Dz group) were compared with a control group of 11 AD patients (6 women and 5 men, mean age 73.5 ± 6.0 years) diagnosed and followed up in the pre-AChEIs era (C group). At basal evaluation (t0), the 2 groups were comparable for age, education, and severity of disease (Global Deterioration Scale). All patients underwent quantitative EEG (qEEG, average reference, 10-20 International System), and were reexamined about 1 year later (t1; i.e., after 12.3 ± 3.6 months the Dz group, and after 13.7 ± 3.9 months the C group). Log-transformed values of two qEEG bands, i.e. 2-6 and 6.5-12 Hz, were averaged between adjacent channels (frontal F3 and F7, F4 and F8; parietotemporal P3 and T7, P4 and T8) to obtain a qEEG ratio (6.5-12/2-6 Hz.) from one frontal and one temporoparietal region in each hemisphere. Neuropsychological impairment was summarized by the Mini-Mental Status Examination (MMSE). At t0, both the MMSE score and the qEEG ratio values were somewhat higher in the C than in the Dz group, although nonsignificantly. Between t0 and t1, the MMSE score decreased significantly (p <0.01) more in the C group (-4.36 ± 2.25) than in the Dz group (-1.45 ± 2.16), as did the qEEG ratio in the right frontal region (p <0.01), whereas in the left frontal region the significance level was not reached (p =0.02). Between t0 and t1, the qEEG ratio difference in both frontal regions and in the right temporoparietal region significantly correlated with the MMSE difference (p <0.01), but neither with time between examinations nor with the difference on the Visual Search Test score. Long-term treatment with Dz led to a lesser deterioration of qEEG, paralleling a milder neuropsychological decline. The effect was significant in frontal regions, possibly because they are relatively spared during the mild-to-moderate phases of the disease.

KW - Alzheimer's disease

KW - Donepezil

KW - Mini-Mental Status Examination

KW - Quantitative EEG

UR - http://www.scopus.com/inward/record.url?scp=0036036651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036036651&partnerID=8YFLogxK

U2 - 10.1159/000063576

DO - 10.1159/000063576

M3 - Article

C2 - 12207147

AN - SCOPUS:0036036651

VL - 46

SP - 49

EP - 56

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 1

ER -